 | • レポートコード：MRC2303E083 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、232ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に569.98百万ドルであった世界のコンパニオンアニマル耳感染症治療市場規模が、2022年に611.98百万ドルに達し、2027年には882.00百万ドルまで年平均7.54%で成長すると予測しています。当調査レポートでは、コンパニオンアニマル耳感染症治療の世界市場について総合的に調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、疾患別分析（外耳炎、内耳炎、中耳炎）、動作モード別分析（口腔、局所）、製品別分析（アミノグリコシド、抗菌、抗真菌、コルチコステロイド、フルオロキノロン）、動物タイプ別分析（猫、犬）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Calder Vets Ltd.、Ceva Santé Animale、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、Merck & Co., Inc.、Penn Veterinary Supply, Inc.、Piedmont Animal Health, Inc.、VCA Inc.、Vedco, Inc.、Vetoquinol S.A.、Vetruus Ltd.、Virbac S.A.、Wedgewood Village Pharmacy, LLC、Zoetis Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のコンパニオンアニマル耳感染症治療市場規模：疾患別 - 外耳炎における市場規模 - 内耳炎における市場規模 - 中耳炎における市場規模 ・世界のコンパニオンアニマル耳感染症治療市場規模：動作モード別 - 口腔治療の市場規模 - 局所治療の市場規模 ・世界のコンパニオンアニマル耳感染症治療市場規模：製品別 - アミノグリコシドの市場規模 - 抗菌の市場規模 - 抗真菌の市場規模 - コルチコステロイドの市場規模 - フルオロキノロンの市場規模 ・世界のコンパニオンアニマル耳感染症治療市場規模：動物タイプ別 - 猫の市場規模 - 犬の市場規模 ・世界のコンパニオンアニマル耳感染症治療市場規模：地域別 - 南北アメリカのコンパニオンアニマル耳感染症治療市場規模 アメリカのコンパニオンアニマル耳感染症治療市場規模 カナダのコンパニオンアニマル耳感染症治療市場規模 ブラジルのコンパニオンアニマル耳感染症治療市場規模 ... - アジア太平洋のコンパニオンアニマル耳感染症治療市場規模 日本のコンパニオンアニマル耳感染症治療市場規模 中国のコンパニオンアニマル耳感染症治療市場規模 インドのコンパニオンアニマル耳感染症治療市場規模 韓国のコンパニオンアニマル耳感染症治療市場規模 台湾のコンパニオンアニマル耳感染症治療市場規模 ... - ヨーロッパ/中東/アフリカのコンパニオンアニマル耳感染症治療市場規模 イギリスのコンパニオンアニマル耳感染症治療市場規模 ドイツのコンパニオンアニマル耳感染症治療市場規模 インドのコンパニオンアニマル耳感染症治療市場規模 フランスのコンパニオンアニマル耳感染症治療市場規模 ロシアのコンパニオンアニマル耳感染症治療市場規模 ... - その他地域のコンパニオンアニマル耳感染症治療市場規模 ・競争状況 ・企業情報 |
The Global Companion Animal Ear Infection Treatment Market size was estimated at USD 569.98 million in 2021 and expected to reach USD 611.98 million in 2022, and is projected to grow at a CAGR 7.54% to reach USD 882.00 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Companion Animal Ear Infection Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Disease Type, the market was studied across Otitis Externa, Otitis Interna, and Otitis Media.
Based on Mode of Operation, the market was studied across Oral and Topical.
Based on Product, the market was studied across Aminoglycosides, Anti-bacterial, Anti-fungal, Corticosteroids, and Fluoroquinolones.
Based on Animal Type, the market was studied across Cats and Dogs.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Companion Animal Ear Infection Treatment market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Ear Infection Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Companion Animal Ear Infection Treatment Market, including Calder Vets Ltd., Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck & Co., Inc., Penn Veterinary Supply, Inc., Piedmont Animal Health, Inc., VCA Inc., Vedco, Inc., Vetoquinol S.A., Vetruus Ltd., Virbac S.A., Wedgewood Village Pharmacy, LLC, and Zoetis Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Companion Animal Ear Infection Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Ear Infection Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Ear Infection Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Companion Animal Ear Infection Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Companion Animal Ear Infection Treatment Market?
6. What is the market share of the leading vendors in the Global Companion Animal Ear Infection Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Ear Infection Treatment Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Number of Pet Owners and Awareness About Animal Hygiene
5.1.1.2. Growing Incidences of Ear Diseases in Pets Associated with a Bacterial Infection
5.1.1.3. Protection of Humans Against Zoonotic
5.1.2. Restraints
5.1.2.1. High Cost of Purchasing and Maintaining the Equipment
5.1.3. Opportunities
5.1.3.1. New Enhancements and Advancements in the Animal Ear Infection Treatments
5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
5.1.4. Challenges
5.1.4.1. Complications after Several Treatments of Ear Infection
5.2. Cumulative Impact of COVID-19
6. Companion Animal Ear Infection Treatment Market, by Disease Type
6.1. Introduction
6.2. Otitis Externa
6.3. Otitis Interna
6.4. Otitis Media
7. Companion Animal Ear Infection Treatment Market, by Mode of Operation
7.1. Introduction
7.2. Oral
7.3. Topical
8. Companion Animal Ear Infection Treatment Market, by Product
8.1. Introduction
8.2. Aminoglycosides
8.3. Anti-bacterial
8.4. Anti-fungal
8.5. Corticosteroids
8.6. Fluoroquinolones
9. Companion Animal Ear Infection Treatment Market, by Animal Type
9.1. Introduction
9.2. Cats
9.3. Dogs
10. Americas Companion Animal Ear Infection Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Companion Animal Ear Infection Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Companion Animal Ear Infection Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Calder Vets Ltd.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Ceva Santé Animale
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Dechra Pharmaceuticals PLC
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Elanco Animal Health Incorporated
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Merck & Co., Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Penn Veterinary Supply, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Piedmont Animal Health, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. VCA Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Vedco, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Vetoquinol S.A.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Vetruus Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Virbac S.A.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Wedgewood Village Pharmacy, LLC
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Zoetis Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing